We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Model Reads and Diagnoses Brain MRI in Seconds

By HospiMedica International staff writers
Posted on 11 Feb 2026

Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability. More...

Delays can be dangerous, especially for conditions that require immediate treatment. Researchers have now developed an artificial intelligence (AI) system that can analyze brain MRIs in seconds, accurately identifying neurological diseases and determining how urgently patients need care.

Researchers at the University of Michigan Health (Ann Arbor, MI, USA) have created an AI system called Prima, designed to function as a neuroradiologist by interpreting brain MRI scans alongside clinical context. Unlike previous AI tools trained on narrow, hand-selected datasets, Prima was trained on more than 200,000 MRI studies comprising 5.6 million imaging sequences collected over decades.

Prima is a vision language model that simultaneously processes images, text, and clinical information. In addition to MRI data, the system incorporates patient medical histories and the clinical reasons imaging was ordered. This allows the model to generate comprehensive assessments, recommend appropriate subspecialists, and flag cases requiring urgent intervention immediately after imaging is completed.

Researchers tested Prima on more than 30,000 MRI studies collected over one year. Across more than 50 neurological diagnoses, the model achieved diagnostic accuracy of up to 97.5% and outperformed other state-of-the-art AI systems. Prima also successfully predicted which cases required higher clinical priority. The findings, published in Nature Biomedical Engineering, show that the system was particularly effective at identifying time-sensitive conditions such as strokes and brain hemorrhages, automatically alerting the appropriate specialists.

The researchers say Prima could help address major challenges in neuroimaging, including workforce shortages, rising imaging volumes, and diagnostic delays. Faster, accurate MRI interpretation could improve outcomes across large health systems as well as resource-limited or rural hospitals. Future work will focus on integrating more detailed electronic medical record data to further refine diagnostic performance. The team also envisions adapting the model to other imaging modalities, including mammography, chest X-rays, and ultrasound, expanding its impact beyond neuroimaging.

“Accuracy is paramount when reading a brain MRI, but quick turnaround times are critical for timely diagnosis and improved outcomes,” said Todd Hollon, MD, senior author of the study. “Prima has the potential to act as a co-pilot for clinicians, delivering fast, reliable insights when they matter most.”

Related Links:
University of Michigan Health


Gold Member
12-Channel ECG
CM1200B
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Blood Gas Analyzer
i-Check200
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.